New treatment strategies are needed for artemisinin-resistant falciparum malaria. This randomized trial shows that neither increasing nor splitting the standard once-daily artesunate dose reverses the markedly reduced parasite clearance rate in patients with artemisinin-resistant falciparum malaria.
Bibliographic Details
Main Authors: |
Das, Debashish,
Tripura, Rupam,
Phyo, Aung Pyae,
Lwin, Khin Maung,
Tarning, Joel,
Lee, Sue J.,
Hanpithakpong, Warunee,
Stepniewska, Kasia,
Menard, Didier,
Ringwald, Pascal,
Silamut, Kamolrat,
Imwong, Mallika,
Chotivanich, Kesinee,
Yi, Poravuth,
Day, Nicholas P. J.,
Lindegardh, Niklas,
Socheat, Duong,
Nguon, Chea,
White, Nicholas J.,
Nosten, François,
Dondorp, Arjen M. |
Format: | Online
|
Language: | English |
Published: |
Oxford University Press
2013
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3563392/
|